Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The Agency is looking to purchase a Coagulation FVIII deficient plasma or equivalent for Batch release of FVIII concentrates and contract work. The current plasma in use is Coagulation FVIII deficient plasma Ref OTXW17 manufactured by Siemens. Agency anticipates to consume 576 mL per year (This is subject to workflows and Agency strategy, as the work is highly variable through the year, and hard to predict).
-Submit response via Atamis e-procurement portal (https://health-family.force.com/s/Welcome)
No supplier information available.